Gran1: A Granulysin-Derived Peptide with Potent Activity against Intracellular


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
04 Aug 2021
Historique:
received: 14 07 2021
revised: 02 08 2021
accepted: 03 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 21 9 2021
Statut: epublish

Résumé

Granulysin is an antimicrobial peptide (AMP) expressed by human T-lymphocytes and natural killer cells. Despite a remarkably broad antimicrobial spectrum, its implementation into clinical practice has been hampered by its large size and off-target effects. To circumvent these limitations, we synthesized a 29 amino acid fragment within the putative cytolytic site of Granulysin (termed "Gran1"). We evaluated the antimicrobial activity of Gran1 against the major human pathogen

Identifiants

pubmed: 34445098
pii: ijms22168392
doi: 10.3390/ijms22168392
pmc: PMC8395039
pii:
doi:

Substances chimiques

Antigens, Differentiation, T-Lymphocyte 0
GNLY protein, human 0
Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : CRC1279
Organisme : Deutsche Forschungsgemeinschaft
ID : CRC1149
Organisme : Deutsche Forschungsgemeinschaft
ID : WE 4223/6-1
Organisme : Deutsche Forschungsgemeinschaft
ID : WE 4223/8-1

Références

J Immunol. 2000 Dec 15;165(12):7102-8
pubmed: 11120840
J Immunol. 2000 Aug 1;165(3):1486-90
pubmed: 10903754
Bioinformatics. 2015 Apr 15;31(8):1325-7
pubmed: 25505092
Front Microbiol. 2018 Oct 30;9:2603
pubmed: 30425706
Methods Cell Biol. 2010;96:603-18
pubmed: 20869540
Int J Dermatol. 2015 Jul;54(7):853-62
pubmed: 25601314
Molecules. 2019 May 07;24(9):
pubmed: 31067828
J Immunol. 1997 Mar 15;158(6):2680-8
pubmed: 9058801
Environ Sci Technol. 2014;48(1):804-10
pubmed: 24328182
Protein Pept Lett. 2010 Apr;17(4):517-21
pubmed: 19961432
J Invest Dermatol. 2005 Aug;125(2):256-63
pubmed: 16098035
J Immunol. 2012 Oct 15;189(8):4069-78
pubmed: 22988030
J Immunol. 2001 Jul 1;167(1):350-6
pubmed: 11418670
Biotechnol Adv. 2016 Sep-Oct;34(5):924-940
pubmed: 27235189
J Intern Med. 2003 Sep;254(3):197-215
pubmed: 12930229
Infect Immun. 2005 Oct;73(10):6332-9
pubmed: 16177304
J Immunol. 2008 Aug 15;181(4):2651-63
pubmed: 18684956
Nucleic Acids Res. 2016 Jan 4;44(D1):D1087-93
pubmed: 26602694
Front Microbiol. 2021 Jan 18;11:618278
pubmed: 33537017
Cell Microbiol. 2011 Oct;13(10):1601-17
pubmed: 21790937
Trends Immunol. 2021 Jun;42(6):469-479
pubmed: 33962888
Tissue Antigens. 2009 Mar;73(3):193-8
pubmed: 19254247
Science. 1998 Oct 2;282(5386):121-5
pubmed: 9756476
Cell. 2004 Dec 17;119(6):753-66
pubmed: 15607973
Nat Med. 2016 Feb;22(2):210-6
pubmed: 26752517
Opt Express. 2014 Mar 24;22(6):7028-39
pubmed: 24664051
Curr Opin Immunol. 2019 Oct;60:19-29
pubmed: 31112765
J Antimicrob Chemother. 2008 May;61(5):1103-9
pubmed: 18310138
J Immunol. 2001 Aug 1;167(3):1222-9
pubmed: 11466337
J Biomol NMR. 1992 Nov;2(6):661-5
pubmed: 1490109
Biochem J. 1999 Dec 15;344 Pt 3:845-9
pubmed: 10585872
Adv Healthc Mater. 2021 Jul;10(14):e2100453
pubmed: 34142469
J Immunol. 2005 Dec 1;175(11):7474-83
pubmed: 16301655
J Antimicrob Chemother. 2003 Jul;52(1):56-60
pubmed: 12775670
Immunity. 2018 Jul 17;49(1):56-65.e4
pubmed: 29958799
Vaccines (Basel). 2018 Sep 14;6(3):
pubmed: 30223448
Science. 2006 Mar 24;311(5768):1770-3
pubmed: 16497887
Antimicrob Agents Chemother. 2005 Jan;49(1):388-97
pubmed: 15616319
Int J Mol Sci. 2020 Sep 14;21(18):
pubmed: 32937921
Biochim Biophys Acta. 2016 May;1858(5):1034-43
pubmed: 26851776
FEBS Lett. 1998 Dec 18;441(2):281-6
pubmed: 9883900
Dis Model Mech. 2011 Sep;4(5):622-33
pubmed: 21729875
Drug Discov Today. 2006 Jan;11(1-2):21-7
pubmed: 16478687
J Immunol. 2005 May 1;174(9):5243-8
pubmed: 15843520
J Immunol. 1998 Aug 15;161(4):1758-64
pubmed: 9712041
Immune Netw. 2020 Feb 11;20(2):e12
pubmed: 32395364
Bioinformatics. 2007 Feb 1;23(3):381-2
pubmed: 17121777

Auteurs

Reiner Noschka (R)

Institute of Medical Microbiology and Hygiene, University Hospital Ulm, 89081 Ulm, Germany.

Fanny Wondany (F)

Institute of Biophysics, Ulm University, 89081 Ulm, Germany.

Gönül Kizilsavas (G)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Tanja Weil (T)

Max Planck Institute for Polymer Research, 55128 Mainz, Germany.

Gilbert Weidinger (G)

Institute of Biochemistry and Molecular Biology, Ulm University, 89081 Ulm, Germany.

Paul Walther (P)

Central Facility for Electron Microscopy, Ulm University, 89081 Ulm, Germany.

Jens Michaelis (J)

Institute of Biophysics, Ulm University, 89081 Ulm, Germany.

Steffen Stenger (S)

Institute of Medical Microbiology and Hygiene, University Hospital Ulm, 89081 Ulm, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH